Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 2
Results: 20
First person profile: Alex A. Adjei, MD, PhD: This multidisciplinary, accomplished cancer clinician and researcher calls oncology the "frontier of medicine".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 168, doi. 10.1002/cncr.34611
- By:
- Publication type:
- Article
People with cancer undergoing immunotherapy can safely receive messenger RNA COVID‐19 vaccines.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 170, doi. 10.1002/cncr.34613
- Publication type:
- Article
Gut microbiota differs significantly between men with and without prostate cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 169, doi. 10.1002/cncr.34612
- Publication type:
- Article
A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non–small cell lung cancer previously treated with a PD‐1 or PD‐L1 inhibitor: Big Ten Cancer Research Consortium BTCRC‐LUN15‐029.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 264, doi. 10.1002/cncr.34565
- By:
- Publication type:
- Article
Immunotherapy partners after progression: Right place, right time?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 181, doi. 10.1002/cncr.34558
- By:
- Publication type:
- Article
Reply to "Micro‐ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI‐RADS 3 lesions".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 322, doi. 10.1002/cncr.34550
- By:
- Publication type:
- Article
Micro‐ultrasound may significantly reduce the proportion of unnecessary prostate biopsies in patients with PI‐RADS 3 lesions.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 320, doi. 10.1002/cncr.34549
- By:
- Publication type:
- Article
The multidisciplinary management of cholangiocarcinoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 184, doi. 10.1002/cncr.34541
- By:
- Publication type:
- Article
TP53‐altered acute myeloid leukemia and myelodysplastic syndrome with excess blasts should be approached as a single entity.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 175, doi. 10.1002/cncr.34535
- By:
- Publication type:
- Article
Landscape and clinical impact of NOTCH mutations in newly diagnosed acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 245, doi. 10.1002/cncr.34534
- By:
- Publication type:
- Article
Early skeletal muscle deconditioning and reduced exercise capacity during (neo)adjuvant chemotherapy in patients with breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 215, doi. 10.1002/cncr.34533
- By:
- Publication type:
- Article
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti‐CD19 chimeric antigen receptor T‐cell efficacy.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 255, doi. 10.1002/cncr.34532
- By:
- Publication type:
- Article
Associations of device‐measured physical activity and sedentary time with quality of life and fatigue in newly diagnosed breast cancer patients: Baseline results from the AMBER cohort study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 296, doi. 10.1002/cncr.34531
- By:
- Publication type:
- Article
Modeling the impact of novel systemic treatments on lung cancer screening benefits.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 226, doi. 10.1002/cncr.34527
- By:
- Publication type:
- Article
Effectiveness of triennial screening with clinical breast examination: 14‐years follow‐up outcomes of randomized clinical trial in Trivandrum, India.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 272, doi. 10.1002/cncr.34526
- By:
- Publication type:
- Article
When the personal becomes political: The impact of the Dobbs decision on women with cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 171, doi. 10.1002/cncr.34522
- By:
- Publication type:
- Article
Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 307, doi. 10.1002/cncr.34520
- By:
- Publication type:
- Article
Immune scoring model based on immune cell infiltration to predict prognosis in diffuse large B‐cell lymphoma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 235, doi. 10.1002/cncr.34519
- By:
- Publication type:
- Article
Treatment‐related adverse events of antibody–drug conjugates in clinical trials: A systematic review and meta‐analysis.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 283, doi. 10.1002/cncr.34507
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 2, p. 161, doi. 10.1002/cncr.33695
- Publication type:
- Article